Autism spectrum disorder. Autistic disorder
Conditions
Interventions
Intervention 1: Control group: Risperidone (Risperdal
Janssen Pharmaceuticals, Beerse, Belgium) started at a dose of 0.5 mg and increased by 0.5 mg per week if there are no side effects (for the first three weeks). The therapeutic range for risperidone w
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
5 Years to 11 Years
Inclusion criteria
Inclusion criteria: Age between 5-11 years Diagnosis of autism spectrum disorder based on DSM-V Patients who have specific behavioral problems such as aggression, hyperactivity, unusual, and stereotyped behaviors
Exclusion criteria
Exclusion criteria: Previous prominent psychiatric disorders (e.g., depression) Comorbidities History of allergy or intolerance to risperidone or L-theanine History of seizure or liver dysfunction History of treatment with antipsychotic medications in the past six months
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Irritability. Timepoint: Beginning of the study and weeks 0 - 5 - 10. Method of measurement: By Aberrant Behavior Checklist-Community (ABC-C). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Shahin Akhondzadeh
Tehran University of Medical Sciences
Outcome results
None listed